In Silico Insider Blog

BiotechCRODiscoveryIn Silico InsiderLeadscope Model ApplierPharmaceuticalPre-ClinicalToxicology

Kevin Cross

September 3, 2025

Assessment of N-Nitrosamine impurities in pharmaceuticals under the ICH M7 guideline.

BiotechCROIn Silico InsiderPharmaceuticalPre-Clinical

Candice Johnson, PhD

August 7, 2025

Integration of (Q)SAR models with experimental data and expert review for endocrine activity assessments.

BiotechCROIn Silico InsiderLeadscope Model ApplierPharmaceuticalPre-ClinicalPredictRegulatory Submission

Candice Johnson, PhD

July 17, 2025

Implementing Protocol-Driven (Q)SAR Mutagenicity Assessments for Pharmaceutical Impurities.

CROIn Silico InsiderPharmaceuticalPre-ClinicalRegulatory ComplianceToxicology

Candice Johnson, PhD

June 5, 2025

In Silico Insider: Candice Johnson, PhD

CROIn Silico InsiderLeadscope Model ApplierPharmaceuticalPre-ClinicalPredictive Toxicology

Candice Johnson, PhD

May 15, 2025

In Silico Insider: Candice Johnson, PhD

BiotechCRODiscoveryIn Silico InsiderKnowledgeScanLeadscope Model ApplierPharmaceuticalPre-ClinicalPredictive Toxicology

Candice Johnson, PhD

March 6, 2025

In Silico Insider: Candice Johnson, PhD

Stay up to Date

Get expert tips, industry news, and fresh content delivered to your inbox.